AR and prostate carcinoma: First, prostate cancer cell line PC-3 cells were expressed with AR WT or AR P767A mutant and treated with 0.1% DMSO as vehicle or 0.01–10 nM DHT for luciferase reporter assay using the promoter of PSA gene which includes two AR binding motif22.